---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-004497"
form_type: "8-K/A"
ticker: "VYNE"
cik: "0001566044"
company_name: "VYNE Therapeutics Inc."
filed_at: "2022-01-14T23:59:59+00:00"
generated_at: "2026-06-27T17:56:57.215024+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# VYNE director Rex Bright dies; board appoints LePore, Sandoval; MST sale yields $20M upfront

## Summary
- Director Rex Bright passed away on Jan 11, 2022; he chaired Compensation Committee and served on Audit Committee.
- Board appointed Patrick LePore to Audit Committee and Elisabeth Sandoval as chair of Compensation Committee on Jan 14, 2022.
- MST franchise sold to Journey Medical for $20M upfront, $5M in 1 year, plus up to $450M in milestone payments.
- Pro forma balance sheet shows cash of $67.9M after sale; discontinued operations eliminate product sales revenues.
- Pro forma net loss from continuing ops for nine months ended Sep 30, 2021 was $37.1M, down from $61.8M historical.

## SEC filing metadata
- accession: 0001104659-22-004497
- form_type: 8-K/A
- ticker: VYNE
- cik: 0001566044
- company_name: VYNE Therapeutics Inc.
- filed_at: 2022-01-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 9.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1566044/000110465922004497/0001104659-22-004497-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1566044/000110465922004497/tm222963d1_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-004497
- JSON: https://secwatch.observer/filing/0001104659-22-004497.json
- Plain text: https://secwatch.observer/filing/0001104659-22-004497.txt

## Key facts
- Executive change
  Rex Bright departed as Director at VYNE Therapeutics Inc..
  - Action: passed away
  - Role: Director
  source text: The Company deeply regrets to announce that Mr. Rex Bright passed away on January 11, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1566044/000110465922004497/0001104659-22-004497-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.